17 - 20 Jun 2024 | Amsterdam

Inclusive clinical trials: Why we really shouldn't still be talking about this in 2024 (but have to!)

Speakers:

Adama Ibrahim

VP Digital Strategy & Change ManagementNovo Nordisk

James O'Shaughnessy

Senior PartnerNewmarket Strategy

Dina Gifkins

Senior Director, Oncology Therapeutic HeadJohnson & Johnson

Cristina Duran

PresidentEvinova

Michelle Longmire

Co-Founder & CEOMedable

About this Session:

In 2022, the US’s National Academy of Sciences, Engineering & Medicine (NASEM) released a damning report into underrepresentation in clinical trials. "While progress has been made with representation of white women in clinical trials and clinical research, there has been little progress in the last three decades to increase participation of racial and ethnic minority population groups." Whilst we celebrate diversity in Europe, from race to gender, sexuality to age, participants in clinical trials remain overwhelmingly white and male. However, until interest and investment to improve diversity and representativeness in trials comes to the forefront, the goals of diversification remain poorly articulated and understood. We all know how important diversity is, but how exactly can we make clinical trials attractive to all?

HLTH Europe 2024

Thrills, pills, & VC bills: What will it take to unleash innovation in the world of drug development?

European champions: How to scale across the European continent

No place like home: Why ‘chez vous' might be the ideal care location

Dream come true, or a neuro nightmare? Improving your sleep with digital solutions

ChatGPT in the hospital: Helping hand or unhelpful hindrance?

The Beat: GAIA - How to succeed as a DiGA: AMA with DiGA pioneers

The Beat: MMB - Bridging the gap: The role of employers in delivering healthcare services

Trust your gut: Advances in metabolic health

Levelling the playing field: Putting equity at the centre of the discussion

Rewriting the script: Setting the electronic health record straight

Stripes, stars, & success: Scaling healthcare startups in the US

Out of the lab and onto a tab: Get ready for the in silico boom

The Beat: ViiV Healthcare - The last mile on healthcare access

The Beat: NovoNordisk - The new face of Pharma: Partner, Investor, Acquirer...Friend?

La Poste - Announcing La Poste Healthcare & Autonomy European expansion

MSD - Launch of the MSD Idea Studio Europe

Yes it is: The future of health is female

Sales: Reclaiming healthcare's dirtiest word

Patience for patients: Ensuring the future of biotech

Bored of borders: Breaking down Europe's silos

Shattering stigmas: Reappraise mental health

Ctrl+Alt+Defeat: Winning the cyber security battle in health

Deloitte - Launch of the European Electronic Health Record Center of Excellence (EHR COE) Center

H&B Tech Talk - H&B&Me App - Little Changes, Big Results - democratising longevity for all from Holland and Barrett

The long & winding road: Healthtech's path to validation

When systems speak to each other: the CIO view on interoperability

Navigating depression: New pathways in mental health

Last mile: Localising access for underserved areas